Phosphorylation of tyrosine 90 in SH3 domain is a new regulatory switch controlling Src kinase
preprint
OA: closed
CC-BY-4.0
Abstract
ABSTRACT The activation of Src kinase in cells is strictly controlled by intramolecular inhibitory interactions mediated by SH3 and SH2 domains. They impose structural constraints on the kinase domain holding it in a catalytically non-permissive state. The transition between inactive and active conformation is known to be largely regulated by the phosphorylation state of key tyrosines 416 and 527. Here we identified that phosphorylation of tyrosine 90 reduces binding affinity of the SH3 domain to its interacting partners, opens the Src structure, and renders Src catalytically active. This is accompanied by an increased affinity to the plasma membrane, decreased membrane motility and slower diffusion from focal adhesions. Phosphorylation of tyrosine 90 controlling SH3-medited intramolecular inhibitory interaction, analogical to tyrosine 527 regulating SH2-C-terminus bond, enables SH3 and SH2 domains to serve as cooperative but independent regulatory elements. This mechanism allows Src to adopt several distinct conformations of varying catalytic activities and interacting properties, enabling it to operate not as a simple switch but as a tunable regulator functioning as a signaling hub in a variety of cellular processes.
My notes (saved in your browser only)
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.
References (43)
- doi:10.3389/fgene.2014.00181 via crossref
- doi:10.1016/j.bpj.2014.12.007 via crossref
- doi:10.1074/jbc.270.41.24222 via crossref
- doi:10.1021/bi960248u via crossref
- doi:10.1038/sj.onc.1208081 via crossref
- doi:10.1038/sj.onc.1207965 via crossref
- doi:10.1016/s0006-291x(02)00884-7 via crossref
- doi:10.1016/j.jmb.2008.08.040 via crossref
- doi:10.1007/bf00124216 via crossref
- doi:10.1006/jmbi.2000.4274 via crossref
- doi:10.1016/j.str.2005.03.012 via crossref
- doi:10.1083/jcb.201802102 via crossref
- doi:10.1002/j.1460-2075.1995.tb07077.x via crossref
- doi:10.1021/acs.jpcb.6b08409 via crossref
- doi:10.1016/s0304-419x(02)00040-9 via crossref
- doi:10.1080/09553000701727531 via crossref
- doi:10.1038/s41598-017-08303-4 via crossref
- doi:10.1002/jcp.22011 via crossref
- doi:10.1038/sj.onc.1203912 via crossref
- doi:10.1091/mbc.e11-03-0207 via crossref
- doi:10.1021/pr301192t via crossref
- doi:10.1093/emboj/18.9.2459 via crossref
- doi:10.1016/j.biocel.2020.105908 via crossref
- doi:10.1016/j.chembiol.2018.10.024 via crossref
- doi:10.1021/pr800187n via crossref
- doi:10.1111/febs.13404 via crossref
- doi:10.1016/0042-6822(64)90301-0 via crossref
- doi:10.1016/j.str.2015.03.009 via crossref
- doi:10.1074/jbc.m605902200 via crossref
- doi:10.1002/(sici)1521-4141(199907)29:07<2269::aid-immu2269>3.0.co;2-# via crossref
- doi:10.1016/s1074-7613(00)80417-3 via crossref
- doi:10.1038/srep01295 via crossref
- doi:10.1016/j.bbrc.2005.03.012 via crossref
- doi:10.1016/j.celrep.2018.09.035 via crossref
- doi:10.1371/journal.pone.0036310 via crossref
- doi:10.1146/annurev.cellbio.13.1.513 via crossref
- doi:10.1006/jmbi.2001.5083 via crossref
- doi:10.1038/srep18476 via crossref
- doi:10.1074/jbc.273.10.5765 via crossref
- doi:10.1016/s1097-2765(00)80356-1 via crossref
- doi:10.1038/385595a0 via crossref
- doi:10.1038/nrc1366 via crossref
- doi:10.1016/s0092-8674(01)00301-4 via crossref
Source provenance
- crossref
- last seen: 2026-06-01T01:00:38.762063+00:00
- europepmc
- last seen: 2026-05-19T01:45:01.086888+00:00
- unpaywall
- last seen: 2026-05-21T05:10:58.409756+00:00
License: CC-BY-4.0